Hematology Clinical Trial Expertise

    Veristat has guided clients through the conduct of more than 100  clinical trials and nearly 20 regulatory agency submissions for blood diseases.  Our experience spans clinical development consulting, full clinical trial oversight and regulatory submission preparation for rare genetic blood disorders, autoimmune  blood diseases as well as blood cancers.

    Non-Malignant Blood Disease Expertise

    Our teams are experienced in designing and running clinical trials for genetic and autoimmume blood disorders including:
    • Aplastic Anemia

    • Diabetes- Blood Glucose Meter

    • Cold Agglutinin Disease (CAD)  

    • Hemophilia

    • Polycythemia Vera  

    • Sickle Cell Disease

    • Thalassemia

    veristat_photo_hematology.png

    Contact Veristat Now


    Request A Proposal

    Contact Us


    Our Malignant Blood Disease Expertise

    Malignant Hematology Diseases 

    Veristat has helped clients plan, conduct and report their clinical trials to the regulatory agencies for the following blood cancers:

    • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    • Chronic Lymphocytic Leukemia  (CLL)

    • Cutaneous T-Cell Lymphoma (CTCL)

    • Diffuse Large B-Cell Lymphoma (DLBCL)

    • Follicular Lymphoma 

    • Hodgkin’s Lymphoma 

    • Mantle Cell Lymphoma

    • Multiple Myeloma (MM)
    • Myeloid Leukemia (AML/CML)
    • Myelofibrosis
    • Myelodysplastic Syndromes (MDS)
    • Peripheral T-Cell Lymphoma (PTCL)
    • Non-Hodgkin’s Lymphoma (NHL)
    • Waldenstrom's  Macroglobulinemia (WM)

     

    Contact Veristat To Learn More

    veristat_candid-5.jpg

    We are privileged to have worked on a variety of innovative, life-extending and life-saving hematology treatments that range from rare genetic blood disorders, to autoimmune disorders, to blood cancers including leukemia and lymphoma.   Our teams have the expertise and experiences to help you design, build, and run your malignant or non-malignant hematology clinical development program. And, we’ll help you navigate the regulatory submission process. Contact us to learn how we can apply our experience and knowledge in bringing blood disease therapies to market, directly to your study.  

     

    Contact Us

    Contact Us
    Request A Proposal